Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
VIP structure

VIP

Other
Phase 2 Research
45%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 100 mcg
Range 50 - 200 mcg
Maintenance 100 mcg 3x daily

Pharmacokinetics

Half-Life 2 min
Onset 1 min
Peak 2 min
Duration 15 min
Bioavailability 85%
Primary Route Subcutaneous

Administration

Routes Nasal, Subcutaneous, Intravenous
Injection Sites Abdomen
Needle Gauge 29-31G
Syringe Type Nasal Spray
Timing Morning, multiple daily

Reconstitution

Diluent Bacteriostatic Water
Volume 5 mL
Concentration 50 mcg/mL
Stability 14 days refrigerated
Vial Sizes 0.5, 1 mg

Special Instructions

Extremely short half-life requires frequent dosing (3x daily minimum). Nasal spray most common delivery for CIRS protocol. Store reconstituted vial in refrigerator.